Francesco D'Amico, MD, PhD, FEBS
Assistant Professor AdjunctCards
About
Research
Publications
2024
Textbook outcome and nomogram-guided approaches for enhancing surgical success in elderly HCC patients: Deciphering the influence of sarcopenia
Lanari J, Lupi A, Billato I, Alessandris R, Crimì F, Caregari S, Pepe A, D’Amico F, Vitale A, Quaia E, Cillo U, Gringeri E. Textbook outcome and nomogram-guided approaches for enhancing surgical success in elderly HCC patients: Deciphering the influence of sarcopenia. Updates In Surgery 2024, 1-10. PMID: 39373845, DOI: 10.1007/s13304-024-01992-3.Peer-Reviewed Original ResearchPsoas muscle indexElderly HCC patientsOverall survivalLiver resectionSarcopenic patientsHepatocellular carcinomaTextbook outcomePostoperative complicationsHCC patientsMedian psoas muscle indexAbsence of postoperative complicationsElderly hepatocellular carcinomaInfluence of sarcopeniaHepatocellular carcinoma nodulesPreoperative CT scanAssociated with sarcopeniaHepatocellular carcinoma patientsNon-sarcopenic individualsSarcopenia's impactOncological outcomesClavien-DindoPrognostic factorsSurgical successMuscle indexPostoperative outcomesEstimation of intraoperative blood loss in hepatopancreatobiliary surgery: a Delphi consensus process of the European–African Hepato-Pancreato-Biliary Association (E-AHPBA)
Perri G, Sparrelid E, Siriwardena A, Marchegiani G, Abu Hilal M, Adam M, Aldrighetti L, Andersson B, Apostolos A, Aroori S, Balakrishnan A, Bassi D, Belli A, Berardi G, Berrevoet F, Besselink M, Bockhorn M, Boggi U, Borscheid R, Bouwense S, Brustia R, Buis C, Burmeister S, Busch O, Cillo U, Coker A, Conlon K, Crippa S, D'Amico F, Dasari B, De Luca R, De Wilde R, Dervenis C, Devar J, Di Martino M, Dokmak S, Ekmekcigil E, Engstrand J, Esposito A, Fretland A, Frigerio I, Gallagher T, Gemenetzis G, Gilg S, Giovinazzo F, Goh B, Guerra M, Guest R, Gulla A, Gumbs A, Hackert T, Hallet J, Hand F, Hartmann D, Healey A, Heinrich S, Hoti E, Ignatavicius P, Jamieson N, Johanna L, Jonas E, Jovine E, Jugmohan B, Kausar A, Keli E, Khan Z, Kirkegard J, Kleeff J, Kron P, Lancellotti F, Lang S, Laudari U, Laukkarinen J, Linecker M, Lopez V, Malik H, Marchetti A, Martel G, Melloul E, Michalski C, Pandanaboyana S, Passas I, Perinel J, Radenkovic D, Ramia J, Rangelova E, Rashidian N, Ratti F, Rebelo A, Rhaiem R, Rotellar F, Sadot E, Sallinen V, Savvas T, Schmelzle M, Serrablo A, Serradilla M, Sgarbura O, Shadde E, Soreide K, Sposito C, Stattner S, Stavrou G, Sternby H, Strobel O, Sturesson C, Tanno L, Tedeschi M, Torzilli G, Tsiotos G, Tsoulfas G, Velazquez P. Estimation of intraoperative blood loss in hepatopancreatobiliary surgery: a Delphi consensus process of the European–African Hepato-Pancreato-Biliary Association (E-AHPBA). British Journal Of Surgery 2024, 111: znae256. PMID: 39387472, DOI: 10.1093/bjs/znae256.Peer-Reviewed Original ResearchThe Italian experience on liver transplantation for unresectable peri-hilar cholangiocarcinoma: a national survey and future perspectives
Gringeri E, Furlanetto A, Billato I, Cescon M, De Carlis L, Mazzaferro V, Romagnoli R, De Simone P, Vivarelli M, Di Benedetto F, Ravaioli M, Lauterio A, Sposito C, Patrono D, Ghinolfi D, Moccheggiani F, Di Sandro S, D’Amico F, Lanari J, Gambato M, Trapani S, Bergamo F, Cardillo M, Burra P, Cillo U. The Italian experience on liver transplantation for unresectable peri-hilar cholangiocarcinoma: a national survey and future perspectives. Updates In Surgery 2024, 1-9. PMID: 39210194, DOI: 10.1007/s13304-024-01889-1.Peer-Reviewed Original ResearchNeoadjuvant radio-chemotherapyPerihilar cholangiocarcinomaLiver transplantationGroup 1Radio-chemotherapyGroup 2Standard of care chemotherapyRisk of cancer-related deathInclusion criteriaPeri-hilar cholangiocarcinomaRecurrence-free survivalResults of LTRisk regression analysisCancer-related deathsLiver transplant centersMayo protocolNeoadjuvant regimenNeoadjuvant treatmentCare chemotherapyOverall survivalProspective studyMayo ClinicHazard ratioTransplant centersIneffective treatmentAdvocating for a “shift-to-left” in transplant oncology: left grafts, RAPID and dual graft
Cillo U, Furlanetto A, Gringeri E, Bertacco A, Marchini A, Rosso E, Bassi D, D’Amico F, Line P. Advocating for a “shift-to-left” in transplant oncology: left grafts, RAPID and dual graft. Updates In Surgery 2024, 1-14. PMID: 39120859, DOI: 10.1007/s13304-024-01919-y.Peer-Reviewed Original ResearchLiving donor liver transplantationRisk of small-for-size syndromeSmall-for-size syndromeDual-graft living donor liver transplantationHigh-volume transplant centerDonor liver transplantationDonor-recipient matchingShortage of graftsLeft-lobeLiver transplantationRight-lobeOncological indicationsTransplant oncologyDonor hepatectomyDual graftsTransplant centersHigh riskLeft graftGraftFull-left/Full-right Liver Splitting With Middle Hepatic Vein and Caval Partition During Dual Hypothermic Oxygenated Machine Perfusion
Cillo U, Lauterio A, Furlanetto A, Canitano N, Polacco M, Buscemi V, De Carlis R, Boetto R, D’Amico F, Bassi D, De Carlis L, Gringeri E. Full-left/Full-right Liver Splitting With Middle Hepatic Vein and Caval Partition During Dual Hypothermic Oxygenated Machine Perfusion. Transplantation 2024, 108: 1417-1421. PMID: 38755751, DOI: 10.1097/tp.0000000000005039.Peer-Reviewed Original ResearchMiddle hepatic veinHypothermic oxygenated machine perfusionOxygenated machine perfusionHepatic veinVena cavaMachine perfusionEffects of ischemia-reperfusion injuryLiver splittingDual hypothermic oxygenated machine perfusionIschemia-reperfusion injuryProlonged cold ischemiaSplit liver transplantationEx situ splittingPediatric patientsVenous reconstructionParenchymal transectionAdult patientsLiver transplantationHepatocellular carcinomaVenous congestionRight graftCold ischemiaVenous outflowProlonged ischemiaImprove outcomesRecurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndrome
Berardi G, Cucchetti A, Sposito C, Ratti F, Nebbia M, D’Souza D, Pascual F, Dogeas E, Tohme S, Vitale A, D’Amico F, Alessandris R, Panetta V, Simonelli I, Colasanti M, Russolillo N, Moro A, Fiorentini G, Serenari M, Rotellar F, Zimitti G, Famularo S, Ivanics T, Donando F, Hoffman D, Onkendi E, Essaji Y, Giuliani T, Ben S, Caula C, Rompianesi G, Chopra A, Abu Hilal M, Sapisochin G, Torzilli G, Corvera C, Alseidi A, Helton S, Troisi R, Simo K, Conrad C, Cescon M, Cleary S, Kwon D, Ferrero A, Ettorre G, Cillo U, Geller D, Cherqui D, Serrano P, Ferrone C, Aldrighetti L, Kingham T, Mazzaferro V. Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndrome. JHEP Reports 2024, 6: 101075. PMID: 38961853, PMCID: PMC11220535, DOI: 10.1016/j.jhepr.2024.101075.Peer-Reviewed Original ResearchLong-term outcomes of liver resectionRecurrence-free survivalTime of recurrenceCancer-specific survivalTumor-related factorsDevelopment of hepatocellular carcinomaHepatocellular carcinomaMetabolic syndromeLong-term survivalRisk factorsOverall survivalImpact survivalResection of hepatocellular carcinomaOutcomes of liver resectionCurative intent approachPost-recurrence survivalPredictors of recurrenceHazard of recurrenceTreatment of recurrenceRisk of recurrenceTumor-related deathLong-term outcomesDesigning future trialsAssociated with deathMedian OSLIVING DONOR LIVER DONATION IN THE ONCOLOGICAL FIELD: WHAT’S NEW
Gringeri E, Furlanetto A, Lanari J, Marchini A, Dolcet A, Bassi D, Boetto R, D’Amico F, Bertacco A, Perin L, Nieddu E, Ballo M, Rosso E, Nardi C, Canitano N, Cillo U. LIVING DONOR LIVER DONATION IN THE ONCOLOGICAL FIELD: WHAT’S NEW. European Journal Of Transplantation 2024, 2: 22-28. DOI: 10.57603/ejt-434.Peer-Reviewed Original ResearchWhat Is the Role of Minimally Invasive Liver Surgery in Treating Patients with Hepatocellular Carcinoma on Cirrhosis?
Vitale A, Angelico R, Sensi B, Lai Q, Kauffmann E, Scalera I, Serenari M, Ginesini M, Romano P, Furlanetto A, D’Amico F. What Is the Role of Minimally Invasive Liver Surgery in Treating Patients with Hepatocellular Carcinoma on Cirrhosis? Cancers 2024, 16: 966. PMID: 38473327, PMCID: PMC10930835, DOI: 10.3390/cancers16050966.Peer-Reviewed Original ResearchMinimally invasive liver surgeryOpen surgeryLiver surgerySignificant cardiovascular riskTrans-arterial approachResection outcomesLaparoscopic ablationResected casesLiver transplantationTreated patientsHepatocellular carcinomaEfficacious therapyCardiovascular riskSurgeryPatientsNarrative reviewTreatment hierarchyCurative techniqueHCCResectionCarcinomaCirrhosisTransplantationTherapyEx situ liver resection for intrahepatic cholangiocarcinoma: survival analysis and comparison to systemic chemotherapy
Nieddu E, Billato I, Peluso C, Furlanetto A, Lazzari S, D'Amico F, Cillo U, Gringeri E. Ex situ liver resection for intrahepatic cholangiocarcinoma: survival analysis and comparison to systemic chemotherapy. Digestive And Liver Disease 2024, 56: s42. DOI: 10.1016/j.dld.2024.01.067.Peer-Reviewed Original ResearchProgression-free survivalCA19-9 levelsEx situ liver resectionOverall survivalIntrahepatic cholangiocarcinomaEx situ surgeryStage of diseasePerformance statusSystemic chemotherapySurgical resectionLiver resectionLiver functionHigh-volume hepatobiliary centersLower stage of diseaseMedian progression-free survivalTreated with surgical resectionEvaluate long-term outcomesSurvival analysisEx situ resectionNon-parametric log-rank testTreated with chemotherapyLog-rank testLiver function testsCox regression analysisLong-term outcomesLiver resection versus radiofrequency ablation or trans-arterial chemoembolization for early-stage (BCLC A) oligo-nodular hepatocellular carcinoma: meta-analysis
Romano P, Busti M, Billato I, D’Amico F, Marchegiani G, Pelizzaro F, Vitale A, Cillo U. Liver resection versus radiofrequency ablation or trans-arterial chemoembolization for early-stage (BCLC A) oligo-nodular hepatocellular carcinoma: meta-analysis. BJS Open 2024, 8: zrad158. PMID: 38323881, PMCID: PMC10848305, DOI: 10.1093/bjsopen/zrad158.Peer-Reviewed Original ResearchConceptsBarcelona Clinic Liver CancerTrans-arterial chemoembolizationDisease-free survivalBarcelona Clinic Liver Cancer-A patientsBenefits of LRLiver resectionRadiofrequency ablationHepatocellular carcinomaOS benefitOverall survivalA patientsBarcelona Clinic Liver Cancer ABarcelona Clinic Liver Cancer stageDisease-free survival benefitRisk ratioOutcomes of LRMeta-analysisComparative cohort studyCase-control studyChina Biological Medicine DatabaseHCC patientsCohort studyPrimary outcomeNewcastle-OttawaQuality of studies